I covered Haw Par Group back in 2019. Hence I think it is time to revisit this company which is trading at multi year lows.
Category: Case Studies
Medpace Holdings Inc (NASDAQ:MEDP) – A High-Growth Investment Opportunity in the CRO Industry
Discover the potential of investing in Medpace Holdings Inc ($MEDP), a leading global CROin the healthcare industry.
uniQure NV (NASDAQ:QURE) – A Prognosis
We study uniQure NV ($QURE), a biotechnology company focused on developing gene therapies for rare diseases.
VolitionRx Limited (NYSE: VNRX) – Enters Commercial Stage for Nu.Q Vet Cancer Test
VolitionRx is commercially introducing a product with a huge addressable market. If successful, the market will rerate the stock.
Boustead SG (SGX:F9D) – Share Price Undervalued, But Lack of Near Term Catalyst
SOTP valuation shows Boustead's share price is undervalued. However, there may be a lack of near term catalyst for a rerate of share price.
uniQure N.V. (NASDAQ:QURE) – World’s Most Expensive Medicine
uniQure's AMT-061 is currently the world's most expensive drug. Here's why investing in $QURE may be rewarded with strong returns.
Five Interesting Earnings Reports At a Pivotal Point For The Market
We look at 5 intriguing earnings report I found during this earnings season
Service Corporation International (NYSE:SCI) – Profiting from “Death”
Service Corporation International (NYSE:SCI) is the leader in the death care industry and expected to grow as demand for its services increase. If an investor is looking for an investment in an industry that will always be in demand, SCI is an excellent choice.
ASA Gold (NYSE:ASA) – Trading at 13% NAV Discount
ASA Gold (ASA) is a closed-end precious metals fund selling at a discount of -13% to NAV. I feel it is a good name to add exposure to gold
Credit Bureau Asia Ltd (SGX: TCU) – A Wide Moat Resilient Business
Credit Bureau Asia Ltd, a leading player in SEA credit and risk information solutions market, is a wide moat resilient business. Here's why.